Clinical Trial

Digital MEDIcal TWIN for the Prediction of Arrhythmic Sudden Cardiac Death After a Myocardial Infarction

Study acronym: TWIN-SCD STEMI
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
TWIN-SCD STEMI is a multicentric prospective, non-randomized pilot study designed to establish a multiparametric model for predicting life-threatening ventricular arrhythmias in patients experiencing their first myocardial infarction. The primary objective of the study is to develop an algorithm with superior predictive performance (sensitivity and specificity) compared to the currently used criterion for the implantation of a cardiac defibrillator, which is a left ventricular ejection fraction (LVEF) of less than 35%.
Trial Details
NCT Number NCT07527494
Lead Sponsor University Hospital, Bordeaux
Conditions Sudden Cardiac Death, Myocardial Infarction
Enrollment 1,000 participants
Start Date 2026-04-15
Primary Completion 2033-12-31 (estimated)
Study Completion 2034-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-14